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the pathogenesis of at least three distinct types of gestational tropho-
blastic neoplasia (GTN), including the most common type, choriocarci-
noma, and two less common ones, placental site trophoblastic tumor
(PSTT) and epithelioid trophoblastic tumor (ETT). Choriocarcinoma is
composed of variable proportions of neoplastic cytotrophoblast,
syncytiotrophoblast, and intermediate trophoblast, the latter of which
is composed of a similar mixture of trophoblastic subpopulations.
While the neoplastic cytotrophoblast in PSTT differentiates mainly
into intermediate trophoblastic cells at the implantation site, the neo-
plastic cytotrophoblast in ETT differentiates into chorionic-type inter-
mediate trophoblastic cells in the chorion laeve. However, the
pathogenesis of the differentiation of GTN, especially ETT, is still un-
known because these tumors are extremely rare. Furthermore, there is
little evidence regarding therapeutic strategies for GTN, including ETT.
Here we present a case of mixed choriocarcinoma coexisting with an
ETT, which might elucidate the pathogenesis of ETT and identify an ap-
propriate treatment approach for mixed-type GTN.2. Case report
A 32-year-old Japanese woman, gravida 2, para 1, visited a previous
hospital complaining of secondary amenorrhea. Her medical history
was notable for treatment with systemic chemotherapy with metho-
trexate (MTX) at age 26 for an invasive hydatidiformmole that had de-
veloped from a complete mole; she had an uncomplicated full-term
delivery 2 years later. Pelvic examination revealed no abnormal ﬁnd-
ings. Her serum human chorionic gonadotropin (hCG) level was
93,820 mIU/ml. Transvaginal ultrasonography showed a mass in the
left uterine horn without a gestational sac. She was ﬁrst diagnosed
with an ectopic pregnancy in the interstitial part of the fallopian tube.
Laparoscopic surgery was performed, resulting in the resection of a⁎ Corresponding author. Department of Mother-Child Nursing, Faculty of Life Sciences,
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hCG levels; while these levels decreased postoperatively, they increased
again 4 weeks later. The presence of residual chorionic villi was
suspected, and she was treated with single-agent chemotherapy with
intramuscularMTX1mg/kgper day on days 1, 3, 5 and 7with intramus-
cular folinic acid 0.1 mg/kg per day on days 2, 4, 6 and 8 every 2 weeks.
After a transient decrease, her serum hCG levels again increased at the
5th cycle of chemotherapy. The patient was referred to Kumamoto Uni-
versity Hospital due to the possible diagnosis of gestational trophoblas-
tic disease. Transvaginal Doppler ultrasound examination showed
extensive vascularization within the myometrium (Fig. 1, A). Pelvic
magnetic resonance imaging demonstrated a high-signal-intensity
focus in the myometrium on T2-weighted images. Evaluation by posi-
tron emission tomography/computed tomography (PET/CT) revealed
increased ﬂuorodeoxyglucose uptake in the uterine mass (Fig. 1, B).
Multiple nodules in both lungs were detected on a CT scan (Fig. 1, C).Fig. 1. Imaging ﬁndings. (A) Transvaginal Doppler ultrasound results show extensive vas-
cularizationwithin themyometrium. (B) A PET/CT image reveals increased FDG uptake in
the mass. (C) A CT image shows multiple nodules in both lungs.
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Fig. 2.Histopathologicalﬁndings of theuterinemass. Choriocarcinoma (►) is composed of
basophilic cells and the ETT (ᐅ) contains eosinophilic cells. Tissuewas stainedwith hema-
toxylin–eosin (HE). Image was taken at 2× magniﬁcation. Scale bar = 50 μm.
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croscopic examination, the tumor displayed biphasic proliferation
(Fig. 2). Histopathological review of the ﬁrst excised specimen
from the previous hospital conﬁrmed a trophoblastic tumor
consisting of the trimorphic proliferation of intermediate trophoblast,
syncytiotrophoblast, and cytotrophoblast, with no chorionic villi, and
the tumor cells showed abnormal mitotic ﬁgures (Fig. 3, A). Tumor
cells were diffusely positive for hCG (Fig. 3, B). Although the histological
and immunohistochemical ﬁndings were characteristics of choriocarci-
noma, the tumor was partially composed of cells that were intimately
associated with surrounding eosinophilic, hyaline-like material and ne-
crotic debris capable of simulating keratin. The cells contained round,
uniform nuclei and eosinophilic or clear cytoplasm surrounded by a
well-deﬁned cell membrane (Fig. 4). Immunohistochemical analysis re-
vealed that the tumor cells were diffusely positive for hCG. Those histo-
logical features of the component indicated characteristics of ETT
notwithstanding the immunopositivity for hCG. Therefore, the patient
was diagnosed with choriocarcinoma coexisting with an ETT.
Combination chemotherapy with etoposide, methotrexate and
actinomycin-D alternating with cyclophosphamide, and vincristine
(EMA-CO) is a standard, effective and well-tolerated regimen for high-
risk GTN. MEA also has the same effectiveness as EMA-CO and less tox-
icity (Matsui et al., 2000), and MEA is one of the standard chemothera-
peutic regimens for choriocarcinoma in Japan. She was treated with 6
cycles of combination chemotherapy consisting of MEA. Her serum
hCG levels normalized and a follow-up CT scan conﬁrmed that the
lung nodules had disappeared. Consequently, she has not undergoneFig. 3.Histopathological and immunohistological ﬁndings of a choriocarcinoma component. Cy
ulation of syncytiotrophoblast, intermediate trophoblast and cytotrophoblast (A). The tumor e
(B). Images were taken at 200× magniﬁcation. Scale bar = 50 μm.additional hysterectomy or chemotherapy, and has had regular men-
strual cycles without recurrence in 26 months since the chemotherapy
with MEA.3. Discussion
Our pathological review of the present case showed amixed chorio-
carcinoma coexisting with an ETT, which is a rare gestational tropho-
blastic tumor. In 1998, Shih and Kurman reported 14 cases of mixed
choriocarcinoma and ETTs, and in more than half the cases there was
a history of either a hydatidiformmole or choriocarcinoma that preced-
ed the diagnosis (Luk and Friedlander, 2013; Shih and Kurman, 1998).
Recently, they proposed that choriocarcinoma, PSTT, or ETT may devel-
op as a result of neoplastic transformation of the same cytotrophoblast,
which is presumably the trophoblastic stem cell (Shih and Kurman,
2001). This theory explains the existence of gestational trophoblastic
neoplasia with mixed histological features, choriocarcinoma, and ETT,
as found in the present case.
Although there is extremely limited experience with choriocarcino-
ma coexisting with an ETT, previous reports suggest that pure-type ETT
may not be responsive to the chemotherapeutic agents used in the
treatment of other types of GTN (Shih, 2007). A high-dose chemothera-
py regimen consisting of cyclophosphamide, etoposide, and carboplatin,
however, resulted in a successful outcome in metastatic ETT (Stacey
et al., 2002). Once treatment has been completed, most relapses occur
within the ﬁrst year of follow-up, and careful hCG monitoring should
be recommended in pure-type ETT (Fieke and Michael, 2014). In this
case, serum hCG ultimately rose within 1 month despite an initial re-
sponse to laparoscopic surgery and MTX under the clinical diagnosis
of an ectopic pregnancy, and residual villi without an adequate patho-
logical examination in the previous hospital. Given the potential for
the progression of choriocarcinoma coexisting with an ETT after our
pathological review,we successfully treated the casewithMEA, the che-
motherapy regimen for the usual form of choriocarcinoma. Repeated
transvaginal ultrasound examinations showed no mass in the uterus,
and serumhCG levels have remained negative for over 2 years, conserv-
ing fertility.
Here we reported a rare case of choriocarcinoma coexisting with an
ETT. The clinical behavior of a mixed choriocarcinoma and ETT seems
similar to that of the usual form of choriocarcinoma despite the
chemoresistance of pure-type ETT. This case suggests that choriocarci-
noma coexisting with an ETT has a high probability of cure with appro-
priate chemotherapy. Study of additional cases is necessary to reliably
determine the behavior of mixed choriocarcinoma coexisting with an
ETT, as well as the optimal multimodal treatment approach.tological atypia and mitotic ﬁgures are numerous. The tumor consists of a trimorphic pop-
xhibits diffuse immunoreactivity with hCG (B). Tissues were stained with HE (A) and hCG
Fig. 4. Histopathological ﬁndings of ETT. A nest of tumor cells with a relatively uniform
population of mononucleate intermediate trophoblastic cells surrounded by necrotic de-
bris and hyaline degeneration. Tissuewas stainedwith HE. Imagewas taken at 200×mag-
niﬁcation. Scale bar = 50 μm.
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